Tilray Brands, Inc. Other Noncash Income (Expense)
Tilray Brands, Inc. (TLRY) reported Other Noncash Income (Expense) of -$1.52 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-07-28
- Tilray Brands, Inc. other noncash income (expense) for the quarter ending 2026-05-31 was $884.00K, a 76.15% decline year-over-year.
- Tilray Brands, Inc. other noncash income (expense) for the quarter ending 2026-02-28 was -$635.00K, a 135.71% decline year-over-year.
- Tilray Brands, Inc. other noncash income (expense) for the quarter ending 2025-11-30 was -$1.49M.
- Tilray Brands, Inc. other noncash income (expense) for the quarter ending 2025-08-31 was -$282.00K.
- Tilray Brands, Inc. other noncash income (expense) for fiscal 2026 was -$1.52M, a 168.91% decline from fiscal 2025.
- Tilray Brands, Inc. other noncash income (expense) for fiscal 2025 was $2.20M.
- Tilray Brands, Inc. other noncash income (expense) for fiscal 2024 was -$13.63M.
- Tilray Brands, Inc. other noncash income (expense) for fiscal 2023 was -$11.41M, a 218.23% decline from fiscal 2022.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 6 month as first filed | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 9 month as first filed | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-05-31 | $884.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $249.00K derived: sum of 2 quarters · filed 2026-07-28 | -$1.24M derived: sum of 3 quarters · filed 2026-07-28 | -$1.52M 10-K · filed 2026-07-28 | |||
| 2026-02-28 | -$635.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-01 | -$2.12M derived: sum of 2 quarters · filed 2026-04-01 | -$2.40M 10-Q · filed 2026-04-01 | $1.30M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2025-11-30 | -$1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | -$1.77M 10-Q · filed 2026-01-08 | $1.94M derived: sum of 3 quarters · filed 2026-07-28 | $3.72M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2025-08-31 | -$282.00K 10-Q · filed 2025-10-09 | $3.42M derived: sum of 2 quarters · filed 2026-07-28 | $5.20M derived: sum of 3 quarters · filed 2026-07-28 | $2.65M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2025-05-31 | $3.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $5.48M derived: sum of 2 quarters · filed 2026-07-28 | $2.93M derived: sum of 3 quarters · filed 2026-07-28 | $2.20M 10-K · filed 2026-07-28 | |||
| 2025-02-28 | $1.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-01 | -$774.00K derived: sum of 2 quarters · filed 2026-04-01 | -$1.50M 10-Q · filed 2026-04-01 | -$1.83M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2024-11-30 | -$2.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | -$3.28M 10-Q · filed 2026-01-08 | -$3.61M derived: sum of 3 quarters · filed 2026-07-28 | -$28.12M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2024-08-31 | -$729.00K 10-Q · filed 2025-10-09 | -$1.06M derived: sum of 2 quarters · filed 2026-07-28 | -$25.57M derived: sum of 3 quarters · filed 2026-07-28 | -$15.17M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2024-05-31 | -$329.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | -$24.84M derived: sum of 2 quarters · filed 2026-07-28 | -$14.44M derived: sum of 3 quarters · filed 2026-07-28 | -$13.63M 10-K · filed 2026-07-28 | |||
| 2024-02-29 | -$24.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-08 | -$14.11M derived: sum of 2 quarters · filed 2025-04-08 | -$13.30M 10-Q · filed 2025-04-08 | -$19.71M derived: sum of 4 quarters · filed 2025-07-29 | |||
| 2023-11-30 | $10.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-10 | $11.21M 10-Q · filed 2025-01-10 | $2.62M 10-Q · filed 2024-01-09 | $4.79M derived: sum of 3 quarters · filed 2025-07-29 | $10.18M derived: sum of 4 quarters · filed 2025-07-29 | ||
| 2023-08-31 | $816.00K 10-Q · filed 2024-10-10 | -$5.60M derived: sum of 2 quarters · filed 2025-07-29 | -$218.00K derived: sum of 3 quarters · filed 2025-07-29 | -$8.51M derived: sum of 4 quarters · filed 2025-07-29 | |||
| 2023-05-31 | -$6.42M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | -$1.03M derived: sum of 2 quarters · filed 2025-07-29 | -$9.33M derived: sum of 3 quarters · filed 2025-07-29 | -$11.41M 10-K · filed 2025-07-29 | |||
| 2023-02-28 | $5.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-09 | -$2.91M derived: sum of 2 quarters · filed 2024-04-09 | -$4.99M 10-Q · filed 2024-04-09 | -$12.93M 10-Q · filed 2023-04-10 | $5.62M derived: sum of 4 quarters · filed 2024-10-10 | ||
| 2022-11-30 | -$8.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-09 | -$10.37M 10-Q · filed 2024-01-09 | -$8.18M 10-Q · filed 2023-01-09 | $237.00K derived: sum of 3 quarters · filed 2024-10-10 | $3.01M derived: sum of 4 quarters · filed 2024-10-10 | ||
| 2022-08-31 | -$2.08M 10-Q · filed 2024-10-10 | $8.53M derived: sum of 2 quarters · filed 2024-10-10 | $11.31M derived: sum of 3 quarters · filed 2024-10-10 | $7.73M derived: sum of 4 quarters · filed 2024-10-10 | |||
| 2022-05-31 | $10.61M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $13.39M derived: sum of 2 quarters · filed 2024-07-30 | $9.81M derived: sum of 3 quarters · filed 2024-07-30 | $9.65M 10-K · filed 2024-07-30 | |||
| 2022-02-28 | $2.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-10 | -$797.00K derived: sum of 2 quarters · filed 2023-04-10 | -$962.00K 10-Q · filed 2023-04-10 | -$2.95M derived: sum of 4 quarters · filed 2023-07-26 | |||
| 2021-11-30 | -$3.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-09 | -$3.74M 10-Q · filed 2023-01-09 | -$5.73M derived: sum of 3 quarters · filed 2023-07-26 | -$5.38M derived: sum of 4 quarters · filed 2023-07-26 | |||
| 2021-08-31 | -$165.00K 10-Q · filed 2022-10-07 | -$2.16M derived: sum of 2 quarters · filed 2023-07-26 | -$1.80M derived: sum of 3 quarters · filed 2023-07-26 | -$1.73M derived: sum of 4 quarters · filed 2023-07-26 | |||
| 2021-05-31 | -$1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | -$1.64M derived: sum of 2 quarters · filed 2023-07-26 | -$1.57M derived: sum of 3 quarters · filed 2023-07-26 | -$1.50M 10-K · filed 2023-07-26 | -$3.02M 10-K · filed 2021-07-28 | ||
| 2021-02-28 | $356.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-06 | $423.00K derived: sum of 2 quarters · filed 2022-04-06 | $490.00K 10-Q · filed 2022-04-06 | ||||
| 2020-11-30 | $67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-01-10 | $134.00K 10-Q · filed 2022-01-10 | |||||
| 2020-09-30 | $143.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$88.00K 10-Q · filed 2020-11-09 | |||||
| 2020-08-31 | $67.00K 10-Q · filed 2021-10-07 | ||||||
| 2020-06-30 | -$93.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$231.00K 10-Q · filed 2020-08-10 | |||||
| 2020-05-31 | -$9.61M 10-K · filed 2022-07-28 | $90.00K 10-K · filed 2021-07-28 | |||||
| 2020-03-31 | -$138.00K 10-Q · filed 2021-05-10 | ||||||
| 2019-09-30 | -$1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$2.08M derived: sum of 2 quarters · filed 2020-11-09 | -$1.75M 10-Q · filed 2020-11-09 | ||||
| 2019-06-30 | -$463.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$141.00K 10-Q · filed 2020-08-10 | |||||
| 2019-05-31 | -$242.00K 10-K · filed 2021-07-28 | ||||||
| 2019-03-31 | $322.00K 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |